Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.73B |
| 2 |
S&P Global
SPGI
|
+$1.46B |
| 3 |
Apple
AAPL
|
+$1.27B |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$957M |
| 5 |
Microsoft
MSFT
|
+$853M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$1.96B |
| 2 |
Tesla
TSLA
|
+$902M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$765M |
| 4 |
Sea Limited
SE
|
+$626M |
| 5 |
Canadian National Railway
CNI
|
+$560M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.15% |
| 2 | Financials | 8.45% |
| 3 | Healthcare | 7.82% |
| 4 | Consumer Discretionary | 7.72% |
| 5 | Communication Services | 5.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4076
Plexus
PLXS
$7.23B
| $2.29M | ﹤0.01% |
28,063
-32,150
| -53% | -$2.68M |
|
4077
Healthcare Services Group
HCSG
$1.53B
| $2.29M | ﹤0.01% |
123,571
-503,343
| -80% | -$8.68M |
|
4078
ImmunityBio
IBRX
$8.1B
| $2.29M | ﹤0.01% |
408,175
+146,476
| +56% | +$899K |
|
4079
AdaptHealth
AHCO
$759M
| $2.29M | ﹤0.01% |
142,695
+42,965
| +43% | +$773K |
|
4080
Paymentus
PAY
$4.86B
| $2.29M | ﹤0.01% |
108,482
+94,646
| +684% | +$2.34M |
|
|
FRW
4081
DELISTED
PWP Forward Acquisition Corp. I Class A Common Stock
FRW
| $2.28M | ﹤0.01% |
233,208
| – | – |
|
|
CVSA
4082
Covista Inc
CVSA
$4.8B
| $2.28M | ﹤0.01% |
76,738
-63,044
| -45% | -$1.69M |
|
4083
CALL
United Microelectronic
UMC
$46.9B
| $2.28M | ﹤0.01% |
250,000
+224,500
| +880% | +$2.22M |
|
4084
Dine Brands
DIN
$452M
| $2.27M | ﹤0.01% |
29,175
-27,747
| -49% | -$2.06M |
|
|
KAMN
4085
DELISTED
Kaman Corp
KAMN
| $2.27M | ﹤0.01% |
52,233
-35,564
| -41% | -$1.51M |
|
|
WBA
4086
CALL
DELISTED
Walgreens Boots Alliance
WBA
| $2.27M | ﹤0.01% |
50,700
-62,400
| -55% | -$3.07M |
|
4087
Vanguard Russell 2000 Value ETF
VTWV
$1.37B
| $2.27M | ﹤0.01% |
16,053
-35,779
| -69% | -$4.99M |
|
4088
iShares Core 80/20 Aggressive Allocation ETF
AOA
$3.28B
| $2.26M | ﹤0.01% |
+32,829
| New | +$2.27M |
|
4089
Lindsay Corp
LNN
$1.18B
| $2.26M | ﹤0.01% |
14,416
-777
| -5% | -$107K |
|
4090
BrightView Holdings
BV
$1.07B
| $2.26M | ﹤0.01% |
166,021
-14,050
| -8% | -$190K |
|
4091
CALL
CME Group
CME
$94.8B
| $2.26M | ﹤0.01% |
+9,500
| New | +$2.23M |
|
|
BHAC
4092
DELISTED
Focus Impact BH3 Acquisition Company Class A Common Stock
BHAC
| $2.26M | ﹤0.01% |
230,089
-101
| -0% | -$992 |
|
|
WNS
4093
DELISTED
WNS Holdings
WNS
| $2.26M | ﹤0.01% |
26,403
+18,725
| +244% | +$1.6M |
|
|
RYZ
4094
Ryerson Holding Corp
RYZ
$1.46B
| $2.26M | ﹤0.01% |
64,405
-33,820
| -34% | -$920K |
|
|
RNAM
4095
DELISTED
Avidity Biosciences
RNAM
| $2.25M | ﹤0.01% |
121,892
+11,659
| +11% | +$198K |
|
|
HERAU
4096
DELISTED
FTAC Hera Acquisition Corp. Units
HERAU
| $2.25M | ﹤0.01% |
228,332
-50,000
| -18% | -$495K |
|
|
SLAC
4097
DELISTED
Social Leverage Acquisition Corp I Class A Common Stock
SLAC
| $2.25M | ﹤0.01% |
229,449
| – | – |
|
4098
iShares S&P Mid-Cap 400 Value ETF
IJJ
$9.03B
| $2.24M | ﹤0.01% |
20,466
-30,719
| -60% | -$3.32M |
|
|
ZYXI
4099
DELISTED
Zynex
ZYXI
| $2.24M | ﹤0.01% |
360,216
-240,340
| -40% | -$1.69M |
|
|
EIGR
4100
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $2.24M | ﹤0.01% |
9,003
-3,819
| -30% | -$604K |
|
Similar funds
Goldman Sachs's Q1 2022 Portfolio in Review
As of Q1 2022, Goldman Sachs held 7,240 positions worth $476B, down 5.5% from $504B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Goldman Sachs's Q1 2022 filing shows 783 new, 2,761 increased, 2,388 reduced and 700 closed positions. Its largest new stake was Shell: 8,819,856 shares worth $484M. The largest sale was Alibaba, an estimated $1.96B.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.
- Goldman Sachs's largest Q1 2022 buy was Shell: 8,819,856 shares worth $484M.
- Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $3.73B increase.
- Goldman Sachs's biggest Q1 2022 reduction was Alibaba, cutting an estimated $1.96B.
- Goldman Sachs fully exited BHP Group Plc American Depositary Shares (Each representing two Ordinary Shares) in Q1 2022, selling an estimated $536M.
- Goldman Sachs's ten largest holdings make up 19% of its $476B portfolio in Q1 2022.
- Goldman Sachs opened 783 new positions and closed 700 in Q1 2022.
- Goldman Sachs's portfolio value fell 5.5% quarter-over-quarter to $476B.
Based on Goldman Sachs's 13F filing for Q1 2022, filed 16 May 2022.